Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Jun-23 4:00 PM View:  | Prometheus Biosciences, Inc. (RXDX) | 16-Jun-23 | Disposition | 7,278 | -- | -- | (42%) 17.28K to 10.0K | |
| 16-Jun-23 4:00 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Jun-23 | Disposition | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 02-Jun-23 6:43 PM View: | Prometheus Biosciences, Inc. (RXDX) | 02-Jun-23 | Acquisition (other) | 10,000 | -- | -- | 58% 17.28K to 27.28K | |
| 02-Jun-23 6:43 PM View: | Prometheus Biosciences, Inc. (RXDX) | 02-Jun-23 | Disposition (other) | 10,000 | -- | -- | (37%) 27.28K to 17.28K | |
| 19-May-23 5:44 PM View: | Prometheus Biosciences, Inc. (RXDX) | 19-May-23 | Grant | 2,278 | -- | -- | 15% 15.0K to 17.28K | |
| 12-Dec-22 4:25 PM View: | Candel Therapeutics, Inc. (CADL) | 09-Dec-22 | Purchase | 35,018 | $1.94 | $67,934.90 | 1162% 3.01K to 38.03K | |
| 12-Dec-22 4:25 PM View: | Candel Therapeutics, Inc. (CADL) | 08-Dec-22 | Private Purchase | 3,014 | $1.70 | $5,123.80 | 100% 0 to 3.01K | |
| 12-May-22 9:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-May-22 | Payment of Exercise | 33,714 | $9.40 | $316,912.00 | (2%) 1.46M to 1.43M | |
| 12-May-22 9:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-May-22 | Option Exercise | 366,130 | -- | -- | 33% 1.1M to 1.46M | |
| 09-May-22 6:45 PM View: | Bausch & Lomb Corp (BLCO) | 05-May-22 | Grant | 472,222 | -- | -- | 100% 0 to 472.22K | |
| 07-Mar-22 5:34 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-22 | Payment of Exercise | 12,643 | $23.61 | $298,501.00 | (1%) 1.11M to 1.1M | |
| 02-Mar-22 9:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-22 | Payment of Exercise | 5,115 | $24.06 | $123,067.00 | (< 1%) 1.11M to 1.11M | |
| 02-Mar-22 9:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Payment of Exercise | 113,557 | $24.35 | $2,765,110.00 | (9%) 1.23M to 1.11M | |
| 02-Mar-22 9:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Option Exercise | 208,231 | -- | -- | 20% 1.02M to 1.23M | |
| 02-Mar-22 9:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-22 | Payment of Exercise | 13,183 | $24.35 | $321,006.00 | (1%) 1.14M to 1.13M | |
| 15-Sep-21 5:15 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Sep-21 | Payment of Exercise | 5,010 | $28.66 | $143,587.00 | (< 1%) 1.04M to 1.03M | |
| 15-Sep-21 5:15 PM View: | Valeant Pharmaceuticals Int... (BHC) | 13-Sep-21 | Payment of Exercise | 3,549 | $29.19 | $103,595.00 | (< 1%) 1.04M to 1.04M | |
| 16-Mar-21 9:48 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Mar-21 | Purchase | 15,000 | $19.00 | $285,000.00 | 100% 0 to 15.0K | |
| 10-Mar-21 9:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-21 | Payment of Exercise | 231,188 | $32.97 | $7,622,270.00 | (18%) 1.27M to 1.04M | |
| 10-Mar-21 9:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Grant | 108,254 | -- | -- | 13% 845.82K to 954.08K | |
| 10-Mar-21 9:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-21 | Option Exercise | 317,089 | -- | -- | 33% 954.08K to 1.27M | |
| 05-Mar-21 6:00 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-21 | Grant | 74,150 | -- | -- | 10% 771.67K to 845.82K | |
| 03-Mar-21 4:47 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-21 | Payment of Exercise | 28,192 | $31.42 | $885,793.00 | (4%) 799.87K to 771.67K | |
| 16-Sep-20 4:09 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-Sep-20 | Payment of Exercise | 5,115 | $15.91 | $81,379.60 | (< 1%) 804.98K to 799.87K | |
| 16-Sep-20 4:09 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Sep-20 | Payment of Exercise | 3,623 | $15.40 | $55,794.20 | (< 1%) 808.6K to 804.98K | |
| 06-May-20 4:02 PM View: | Valeant Pharmaceuticals Int... (BHC) | 04-May-20 | Payment of Exercise | 95,489 | $17.16 | $1,638,590.00 | (11%) 904.09K to 808.6K | |
| 11-Mar-20 9:03 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Mar-20 | Payment of Exercise | 18,488 | $20.96 | $387,508.00 | (2%) 922.58K to 904.09K | (4%) |
| 03-Mar-20 5:28 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-20 | Payment of Exercise | 4,925 | $22.52 | $110,911.00 | (< 1%) 927.5K to 922.58K | |
| 03-Mar-20 5:28 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-20 | Payment of Exercise | 9,269 | $24.44 | $226,534.00 | (< 1%) 936.77K to 927.5K | |
| 28-Feb-20 7:33 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-20 | Grant | 81,040 | -- | -- | 9% 855.73K to 936.77K | |
| 18-Sep-19 5:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 16-Sep-19 | Payment of Exercise | 5,115 | $23.24 | $118,873.00 | (< 1%) 860.85K to 855.73K | |
| 13-Sep-19 9:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 13-Sep-19 | Grant | 21,248 | -- | -- | 3% 809.6K to 830.85K | |
| 13-Sep-19 9:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 13-Sep-19 | Market Purchase | 30,000 | $23.31 | $699,300.00 | 4% 830.85K to 860.85K | |
| 12-Mar-19 4:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-19 | Payment of Exercise | 18,658 | $23.56 | $439,582.00 | (2%) 828.26K to 809.6K | < 1% |
| 28-Feb-19 4:10 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-19 | Grant | 30,000 | -- | -- | 4% 687.08K to 717.08K | |
| 28-Feb-19 4:10 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-19 | Market Purchase | 30,000 | $23.67 | $710,100.00 | 4% 717.08K to 747.08K | < 1% |
| 01-Mar-19 5:14 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-19 | Grant | 81,182 | -- | -- | 12% 687.08K to 768.26K | |
| 17-Sep-18 2:56 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Sep-18 | Grant | 30,000 | -- | -- | 5% 627.08K to 657.08K | |
| 17-Sep-18 2:56 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Sep-18 | Market Purchase | 30,000 | $22.32 | $669,600.00 | 5% 657.08K to 687.08K | 6% |
| 04-May-18 5:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-May-18 | Payment of Exercise | 91,942 | $18.31 | $1,683,460.00 | (13%) 719.02K to 627.08K | (29%) |
| 13-Mar-18 4:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 13-Mar-18 | Market Purchase | 30,000 | $16.05 | $481,500.00 | 4% 689.02K to 719.02K | 48% |
| 09-Mar-18 8:47 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Mar-18 | Grant | 113,652 | -- | -- | 20% 575.37K to 689.02K | |
| 13-Jun-16 6:47 AM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Jun-16 | Market Purchase | 202,000 | $24.48 | $4,944,960.00 | 9% 2.24M to 2.44M | (3%) |
| 04-May-16 5:00 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-May-16 | Grant | 2,240,200 | -- | -- | 100% 0 to 2.24M | |
| 30-Dec-15 3:18 PM View: | Perrigo Co Plc (PRGO) | 28-Dec-15 | Option Exercise | 10,183 | $58.82 | $598,964.00 | 9% 119.42K to 129.6K | |
| 30-Dec-15 3:18 PM View: | Perrigo Co Plc (PRGO) | 28-Dec-15 | Market Option Sale | 10,183 | $147.07 | $1,497,580.00 | (8%) 129.6K to 119.42K | 75% |
| 25-Aug-15 6:21 PM View: | Perrigo Co Plc (PRGO) | 21-Aug-15 | Grant | 16,499 | $186.89 | $3,083,500.00 | 15% 107.92K to 124.42K | (80%) |
| 25-Aug-15 6:21 PM View: | Perrigo Co Plc (PRGO) | 21-Aug-15 | Payment of Exercise | 12,374 | $186.89 | $2,312,580.00 | (9%) 131.79K to 119.42K | 80% |
| 25-Aug-15 6:21 PM View: | Perrigo Co Plc (PRGO) | 21-Aug-15 | Option Exercise | 7,365 | $186.89 | $1,376,440.00 | 6% 124.42K to 131.79K | (80%) |
| 30-Dec-15 3:18 PM View: | Perrigo Co Plc (PRGO) | 13-Mar-15 | Gift | 900 | -- | -- | (< 1%) 119.42K to 118.52K |